CLARCOR Inc. (NYSE:CLC) shares increased 2.36% in last trading session and ended the day at $58.46. CLC Gross Margin is 33.00% and its has a return on assets of 7.00%. CLARCOR Inc. (NYSE:CLC) quarterly performance is 17.69%.
On 16 March, CLARCOR Inc. (NYSE: CLC) reported that its diluted earnings per share of $0.43 in the first quarter of 2016 declined $0.10 from the first quarter of 2015. This decline primarily resulted from an approximate $0.08 reduction from weaker year-over-year end-markets in the Engine/Mobile Filtration segment, an approximate $0.01 reduction from upfront expenses for cost reduction initiatives incurred in the first quarter of 2016 in our Industrial/Environmental Filtration segment and an approximate $0.01 reduction from the third quarter 2015 disposition of the packaging business, J.L. Clark, which was sold in June 2015.
ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV) ended the last trading day at $1.67. Company weekly volatility is calculated as 24.29% and price to cash ratio as 4.65. ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV) showed a weekly performance of 31.50%.
ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) announced that it intends to offer shares of its common stock and warrants to purchase shares of its common stock in a “best efforts” underwritten public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
On 29 March, NeuroMetrix Inc. (NASDAQ:NURO) shares increased 0.62% and was closed at $1.62. NURO EPS growth in last 5 year was 40.70%. NeuroMetrix Inc. (NASDAQ:NURO) year to date (YTD) performance is -18.18%.
NeuroMetrix, Inc. (NASDAQ: NURO) announced that Premera Blue Cross, a leading health plan in the Pacific Northwest, will pilot the Quell® Wearable Pain Relief device within their organization. Through this innovative collaboration, Premera will provide Quell devices to selected employees with chronic pain. The pilot will assess employees’ response to the technology and its impact on their pain and quality of life. The pilot will also analyze numerous objective data points including device utilization and sleep metrics that are automatically captured via Quell’s smartphone app.
Xcel Energy Inc. (NYSE:XEL) shares increased 1.21% in last trading session and ended the day at $41.66. XEL Gross Margin is 91.50% and its has a return on assets of 2.60%. Xcel Energy Inc. (NYSE:XEL) quarterly performance is 17.55%.
The Xcel Energy Inc. (NYSE: XEL) board of directors raised the quarterly dividend on the company’s common stock from 32 cents per share to 34 cents per share, which is equivalent to an annual rate of $1.36 per share. The Board declared the first quarter common stock dividend payable April 20, 2016, to shareholders of record on March 15, 2016.
ArcelorMittal SA (ADR) (NYSE:MT) caters to the Basic Materials space. It has a net profit margin of -12.50% and weekly performance is -0.68%. On the last day of trading company shares ended up at $4.36. ArcelorMittal SA (ADR) (NYSE:MT) distance from 50-day simple moving average (SMA50) is 10.61%.
ArcelorMittal SA(ADR) (NYSE:MT) announces the terms of its c.USD 3bn rights issue, the principle of which was announced on 5 February 2016 (the “Offering”), following the adoption of enabling resolutions by the Extraordinary General Meeting of shareholders on 10 March 2016. The Offering is underwritten by a syndicate of banks led by Goldman Sachs International, BofA Merrill Lynch and Crédit Agricole Corporate and Investment Bank acting as Joint Global Coordinators and Joint Bookrunners.